Vosoritide
Vosoritide (BMN 111) is a CNP analog that acts as an NPR-B agonist to inhibit FGFR3 signaling. It is a key research tool for studying the pathophysiology of achondroplasia and has been evaluated in both in vitro models and clinical trials for potential therapeutic applications.
Product Specifications
Field of Research
Cardiovascular Research, Signal Transduction
Molecular Weight
4102.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog